Septerna Inc
NASDAQ:SEPN

Watchlist Manager
Septerna Inc Logo
Septerna Inc
NASDAQ:SEPN
Watchlist
Price: 26.41 USD 3.77% Market Closed
Market Cap: 1.2B USD

During the last 3 months Septerna Inc insiders have not bought any shares, and sold 63.2k USD worth of shares. The stock price has increased by 17% over this period (open performance analysis).

The last transaction was made on Nov 10, 2025 by Long Daniel D. , who sold 63.2k USD worth of SEPN shares.

Last Transactions:
Long Daniel D.
$-63.2k
Ezekowitz Alan
$+92.3k
Ezekowitz Alan
$+248.1k
Ezekowitz Alan
$+220.3k
Ezekowitz Alan
$+47.5k
Finer Jeffrey
$+17.4k
Labrucherie Gil M
$+21.8k
Finer Jeffrey
$+22.8k
Finer Jeffrey
$+56.8k
Labrucherie Gil M
$+35.1k
Third Rock Ventures V, L.p.
$+113.1k
Third Rock Ventures V, L.p.
$+2.5m
Labrucherie Gil M
$+29.3k
Third Rock Ventures V, L.p.
$+3.6m
Labrucherie Gil M
$+85.2k
Labrucherie Gil M
$+57.8k
Third Rock Ventures V, L.p.
$+6.7m
Ra Capital Healthcare Fund Lp
$+68.9m
View All Transactions

During the last 3 months Septerna Inc insiders have not bought any shares, and sold 63.2k USD worth of shares. The stock price has increased by 17% over this period (open performance analysis).

The last transaction was made on Nov 10, 2025 by Long Daniel D. , who sold 63.2k USD worth of SEPN shares.

Sold
0-3
months
63.2k USD
1
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
4
7.2m USD

Septerna Inc
Insider Trading Chart

Septerna Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Septerna Inc
Last Insider Transactions

Global
Insiders Monitor

Septerna Inc
Glance View

Market Cap
1.2B USD
Industry
Pharmaceuticals

Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. The company is headquartered in South San Francisco, California and currently employs 73 full-time employees. The company went IPO on 2024-10-25. The firm is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. The company is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with significant unmet needs. The company is focused in major therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.

SEPN Intrinsic Value
4.91 USD
Overvaluation 81%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top